Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series

Eur Heart J Cardiovasc Pharmacother. 2021 Jan 16;7(1):78-80. doi: 10.1093/ehjcvp/pvaa087.
No abstract available

MeSH terms

  • Acute Disease
  • COVID-19 / complications*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / drug therapy*
  • Retrospective Studies
  • SARS-CoV-2*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator